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Virions of porcine reproductive and respiratory syndrome virus (PRRSV) contain six membrane proteins:
the major proteins GP5 and M and the minor proteins GP2a, E, GP3, and GP4. Here, we studied the envelope
protein requirements for PRRSV particle formation and infectivity using full-length cDNA clones in which the
genes encoding the membrane proteins were disrupted by site-directed mutagenesis. By transfection of RNAs
transcribed from these cDNAs into BHK-21 cells and analysis of the culture medium using ultracentrifugation,
radioimmunoprecipitation, and real-time reverse transcription-PCR, we observed that the production of viral
particles is dependent on both major envelope proteins; no particles were released when either the GP5 or the
M protein was absent. In contrast, particle production was not dependent on the minor envelope proteins.
Remarkably, in the absence of any one of the latter proteins, the incorporation of all other minor envelope
proteins was affected, indicating that these proteins interact with each other and are assembled into virions as
a multimeric complex. Independent evidence for such complexes was obtained by coexpression of the minor
envelope proteins in BHK-21 cells using a Semliki Forest virus expression system. By analyzing the maturation
of their N-linked oligosaccharides, we found that the glycoproteins were each retained in the endoplasmic
reticulum unless expressed together, in which case they were collectively transported through the Golgi
complex to the plasma membrane and were even detected in the extracellular medium. As the PRRSV particles
lacking the minor envelope proteins are not infectious, we hypothesize that the virion surface structures formed
by these proteins function in viral entry by mediating receptor binding and/or virus-cell fusion.
Porcine reproductive and respiratory syndrome virus (PRRSV)
belongs to the family of Arteriviridae, which also comprises
Equine arteritis virus (EAV), Lactate dehydrogenase-elevating
virus (LDV), and Simian hemorrhagic fever virus (24, 42). This
family belongs to the order of Nidovirales, together with the
Coronaviridae, Toroviridae, and Roniviridae (2, 3). Arteriviruses
are enveloped RNA viruses that contain a positive-strand
RNA genome and synthesize a 3 nested set of six or eight
subgenomic RNAs (sgRNAs) that encode the structural pro-
teins. Analyses of purified virions of PRRSV have indicated
that they are composed of seven proteins, i.e., four envelope
glycoproteins named GP2a (encoded by open reading frame 2a
[ORF2a]), GP3 (ORF3), GP4 (ORF4), and GP5 (ORF5); a
nonglycosylated membrane protein M (ORF6); the nucleocap-
sid protein N (ORF7); and a nonglycosylated envelope protein,
E, that is expressed from a second ORF (ORF2b) entirely
contained within ORF2 (22, 25, 35, 48). The 29- to 30-kDa
GP2a and 31- to 35-kDa GP4 proteins are both putative class I
integral membrane proteins with an N-terminal signal se-
quence and a C-terminal membrane anchor, containing two
and four predicted N-glycosylation sites, respectively (22). The
E protein is a small 10-kDa protein with a potential N-terminal
N-myristoylation site and a casein kinase II phosphorylation
site, a central hydrophobic domain, and a hydrophilic C ter-
minus containing a cluster of basic residues (32). The E protein
was reported to be the predominant product of sgRNA2 (48).
The 45- to 50-kDa GP3 protein is highly glycosylated poten-
tially by seven N-linked oligosaccharides and has a single N-
terminal hydrophobic domain (22). Whereas the GP3 protein
was shown to be incorporated into virions of European-type
strains (35), for North American strains, its structural nature
has been questioned (11, 19). For EAV, GP2b, GP3, and GP4
have been reported to exist as covalently linked heterotrimeric
complexes (45). Furthermore, incorporation of these glyco-
proteins and of the E protein in EAV particles was shown to be
interdependent (43). The GP5 and M proteins exist as disul-
fide-linked heterodimers in PRRSV particles (20). The mem-
brane topologies of these proteins have not yet been accurately
determined, but by analogy with LDV (8), the M protein is
assumed to be a class III integral membrane protein with an
N-terminal ectodomain of only 16 amino acids followed by
three membrane-spanning domains and a C-terminal endodo-
main of about 78 residues (22). The GP5 protein is assumed to
consist of an N-terminal signal sequence of approximately 30
amino acids, followed by an ectodomain of approximately 35
residues with a variable number of potential N-glycosylation
sites, a long hydrophobic region of about 60 residues that is
presumed to span the membrane one to three times, and a
hydrophilic C terminus of approximately 70 amino acids (22).
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Little is known about the structural requirements for
PRRSV virion formation and infectivity. Several studies point
towards an important role for the GP5 and M proteins in
PRRSV assembly (38, 39), but nothing is yet known about the
function of the minor structural proteins. Recently, Welch and
coauthors (40) demonstrated that the ORF2a/b or ORF4 prod-
ucts are essential for a North American strain of PRRSV;
mutant genomes from which these ORFs had been deleted did
not generate infectivity for reasons that were not investigated.
In the case of EAV, each of the structural proteins was shown
to be required for the production of infectious progeny virus
(26). It appeared that the homologous GP5 and M proteins are
essential for virus assembly, in contrast to the minor envelope
proteins, which are dispensable for virus assembly but not for
EAV infectivity (43).
The aim of the present study was to determine the mem-
brane protein requirements for PPRSV virion formation and
infectivity using a collection of infectious cDNA clones in
which the correct expression of each of these proteins was
individually disabled. The results indicated that while the ma-
jor proteins are essential for particle formation, the minor
proteins are essential for virus infectivity. Furthermore, the
results indicated that the minor proteins are incorporated into
virions as a multimeric complex. Independent confirmation of
this interaction between these proteins was indeed obtained by
their coexpression in cells using a Semliki Forest virus (SFV)
expression system which showed that the glycoproteins are
retained in the endoplasmic reticulum (ER) unless all are
expressed together.
MATERIALS AND METHODS
Cells, viruses, and antibodies. BHK-21 cells were grown in Glasgow minimal
essential medium (Gibco BRL) complemented with 5% fetal bovine serum
(FBS), 10% tryptose phosphate broth, 20 mM HEPES (pH 7.4), 2 mM glu-
tamine, 100 U ml1 penicillin, and 100 U ml1 streptomycin. Porcine alveolar
lung macrophages (PAMs) were maintained in MCA-RPMI 1640 medium
(Gibco BRL) containing 5% FBS, 500 U ml1 penicillin, and 500 U ml1
streptomycin (42). LV4.2.1, a derivative of the original Lelystad virus (LV) Ter
Huurne strain, which has been adapted for growth on MA-104 cells and deriv-
atives thereof (35), was propagated in MARC-145 cells (16). The following
antibodies were used for immunoprecipitation of PRRSV structural proteins:
polyclonal rabbit serum p690, raised against a Lelystad virus-specific peptide
consisting of amino acids 64 to 78 of the GP2a protein (22); monoclonal antibody
(MAb) WBE2, directed against the GP3 protein (6); MAb 122.1, directed against
amino acids 40 to 79 of the GP4 protein (35); MAb 126.3, directed against an
epitope on the ectodomain of the M protein (39); and MAb 122.17, directed
against the PRRSV N protein (35). MAb 3AH9, raised against amino acids 170
to 201 of the GP5 protein (30), was used to detect the expression of the GP5
protein in an immunoperoxidase monolayer assay (IPMA). MAb1, directed
against the bovine herpesvirus type 1 gE/gI protein complex, was used as a
control in the affinity purification assays (36).
Generation of full-length gene knockout constructs and complementing ex-
pression vectors. Using site-directed PCR mutagenesis (Table 1) and shuttle
plasmids, mutant full-length PRRSV cDNA clones were generated in which the
ORFs were disrupted either by mutating their translation initiation codons
(KO2a, KO2b, KO5, and KO6), or by deleting the ORF from just after the
termination codon of the preceding ORF to 40 nucleotides 5 of the transcrip-
tion-regulating sequence of the subsequent ORF (KO3 and KO4) (Table 1 and
Fig. 1A). Mutations were introduced into pABV437, the PacI mutant of the
genome-length cDNA clone of LV (21).
Construct pABV952 was used as a negative control; this construct contains a
deletion from just after the termination codon of PRRSV ORF1ab to the tran-
scription-regulating sequence of ORF7 (Table 1 and Fig. 1A) and consequently
lacks an essential RNA replication signal located in ORF6 (M. V. Kroese et al.,
unpublished results). This construct will be referred to below as “R” (replica-
tion negative).
To produce the lacking proteins in trans, sequences encoding these proteins
were cloned into the pCIneo mammalian expression vector (Promega). For this
purpose, ORFs 2a and 2b of pABV437 were amplified using the respective
oligonucleotides located upstream and downstream of the respective ORFs (Ta-
ble 1). The nucleotide sequences directly upstream of the initiator codons of the
ORFs were modified according to a Kozak consensus sequence. In addition, the
restriction sites XbaI and NotI were added upstream and downstream of the
ORFs, respectively. The PCR fragments were digested with XbaI and NotI and
ligated into the similarly digested pCIneo vector. This resulted in plasmids
pABV782 and pABV783, containing ORFs 2a and 2b, respectively. All PCR-
generated plasmids were verified by sequencing of the entire insert.
TABLE 1. Primers used to generate the mutant full-length cDNAs and the pCIneo expression constructs containing
ORFs 2a and 2b of PRRSV LV
Primer
designationa Primer sequence (533)
b Nucleotide
positionc Purpose
LV183 () GCCGTGAATTCGGGGTGTAGCAATGGGG 11779 KO2a
LV25 () AATCGGATCCTGGTCAGCTCGAATGATGTG 12529 KO2a and KO2b
LV189A () GCCGTGAATTCGGGGTGATGCAGTGGGGTCAC 11779 KO2b
LV250 () ACTGGGCCCTCAGCTCGAATGATG 12531 KO3
LV253 () ACTGGGCCCTTATCGTGATGTACTGGGGAGTAC 13178 KO4
LV90 () TCGACTTGTCGCTAGTATGC 10798 KO3, KO4, and R
LV186 () TGTTCGCCATTCTCTTGGCAATCTGAGATGT 13472 KO5
LV38 () AATCGGATCCTCTGGTTTTTACCGGCC 14600 KO5
LV96 () CCAACTGCAGACCGGATGTCC 12025 KO6
LV187 () ATCGTCTAGGCCTCCCACTGCTCAGCC 14078 KO6
LV407 () AGGCGGCAGCCGGGGCTTGCCTAGCTCTACCTGC 11737 R
LV408 () ATGTTAACGACGCGTCGTCACGGCACTTGCCCAGGCGGCAGCCG 11759 R
LV271 () GCTCTAGAGCCGCCGCCATGCAATGGGGTCACTGTGG 11796 pCIneo-ORF2a; incorporation of XbaI
plus consensus Kozak sequence
LV278 () ATAGTTTAGCGGCCGCTCAGCTCGAATGATGTGTTGC 12525 pCIneo-ORF2a; incorporation of NotI
LV272 () GCTCTAGAGCCGCCGCCATGGGGTCACTGTGGAG 11801 pCIneo-ORF2b; incorporation of XbaI
plus consensus Kozak sequence
LV279 () ATAGTTTAGCGGCCGCTCATAGGACCTTCGATAGTTCG 12013 pCIneo-ORF2b; incorporation of NotI
a Positive-sense primers and negative-sense primers are marked by a  and , respectively.
b The restriction sites are indicated by single underlining, and the consensus Kozak sequence is indicated by double underlining. The mutated translation initiation
sites are indicated in boldface type.
c The position of each primer with respect to the nucleotide sequence of PRRSV LV (GenBank accession no. M96262).
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Expression of GP2a, E, GP3, and GP4 by recombinant Semliki Forest virus. To
study the interdependence of the minor glycoproteins GP2a, GP3, and GP4 for
intracellular transport, these proteins were expressed by the SFV expression
system as developed by Liljestrom and Garoff (18). ORF3 of LV was cloned in
expression vector pSFV1 (18) as described previously for ORF2d (pABV262)
(25) and ORF4 (pABV265) (23). For the design of the recombinant SFV con-
structs, see Fig. 1B. Briefly, ORF3 was excised from plasmid pABV224 (22) with
KpnI and PstI, treated with Klenow polymerase, and ligated into the SmaI site of
expression vector pSFV1, which had been dephosphorylated using calf intestine
phosphatase. This resulted in plasmid pABV267. Plasmid pABV267 turned out
to contain two complete copies of ORF3 in the same orientation but was ob-
served to express the GP3 protein correctly. Recombinant SFV was prepared
according to the methods described previously by Liljestrom and Garoff (18).
In vitro transcription of RNA, electroporation of BHK-21 cells, and inocula-
tion of PAMs. The in vitro generation of full-length PRRSV transcripts and the
electroporation of BHK-21 C13 cells to transfect these transcripts have been
previously described (47). To examine the viability of the PRRSV knockout
mutants, the transfected BHK-21 cells were fixed 24 h posttransfection, and
immunostaining (IPMA [see below]) was performed with an antibody to the N
protein. For analysis of infectious progeny produced by the BHK-21 cells, the
culture supernatants of the transfected cells were used to inoculate PAMs (pas-
sage 1 [p1]). After incubation for 24 h at 37°C, these cells were also fixed for
IPMA, and the culture supernatants were inoculated once again onto new PAMs
(p2), followed by an IPMA on the cells 24 h later.
Rescue of PRRSV knockout mutants. In vitro-synthesized RNA transcripts of
the mutant full-length cDNAs and complementing pCIneo cDNAs were cotrans-
FIG. 1. Composition of the PRRSV constructs. (A) Design of the PRRSV knockout constructs. Depicted are the point mutations of the
initiation codons of ORF2a (KO2a), ORF2b (KO2b), ORF5 (KO5), and ORF6 (KO6); the deletions in ORF3 (KO3) and ORF4 (KO4); and the
deletion of ORF2 to ORF7 (R). The names of the constructs and the nucleotide (nt) positions of the mutations are shown on the right. (B) Design
of the recombinant SFV constructs. Restriction enzyme sites, their positions in the nucleotide sequence of PRRSV LV (GenBank accession no.
M96262), and the names of the constructs providing the genes (pABV) are indicated.
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fected by electroporation into BHK-21 cells which were subsequently incubated
under standard conditions. To study whether complementation of the gene
knockout mutants had occurred, the culture medium was harvested and two
passages on PAMs were performed as described above.
IPMA. Immunostaining of BHK-21 cells and of PAMs was performed with the
aforementioned MAbs against the GP3, GP4, GP5, M, and N proteins by the
method described previously by Wensvoort et al. (41). Expression of the GP2a
and E proteins could not be investigated in the IPMA since reactive antibodies
are currently unavailable.
Metabolic labeling of cells and virus. Twelve hours after transfection of
BHK-21 cells with the full-length PRRSV RNAs, the cells were washed three
times with starvation medium (MEM-E without L-methionine, L-cysteine, and
L-glutamine [ICN]) and subsequently incubated with the same medium supple-
mented with 1.5 mg ml1 methionine and 24 mg ml1 cysteine, 1% L-glutamine,
100 U ml1 penicillin, 100 U ml1 streptomycin, and 5% dialyzed FBS. After 1
hour, 157.5 mCi Tran[35S] label (ICN) was added, and the cells were further
incubated for 5 h at 37°C. After clarification of the culture supernatants at 6,000
rpm for 10 min at 4°C with a Hermle ZK380, the labeled viruses were pelleted
through a 0.5 M sucrose cushion (in 20 mM Tris-HCl, pH 7.6, 100 mM NaCl, and
1 mM EDTA) by ultracentrifugation (Beckman R65 rotor at 48,000 rpm for 3 h
at 4°C). The labeling of LV virions propagated in MARC-145 cells and the
purification of labeled extracellular virions by sucrose cushion have been previ-
ously described (25).
Pulse-chase labeling of BHK-21 cells infected with recombinant SFVs. The
pulse-chase labeling of BHK-21 cells infected with recombinant SFVs has been
described previously (25). Briefly, BHK-21 cells were infected with one or more
recombinant SFVs at a multiplicity of infection (MOI) of 5 each. At 18 h
postinfection (p.i.), the cells were starved for methionine for 30 min followed by
a pulse with L-[35S]methionine for 30 min. Subsequently, the cells were chased
with 5 mM nonradioactive L-methionine for 0, 150, and 300 min or for the time
periods indicated in the legends to Fig. 4 to 6.
Affinity purification of viral particles. To isolate viral particles using affinity
purification, the virus pellets were resuspended in phosphate-buffered saline
(PBS) supplemented with protease inhibitors (Pefabloc-Sc [25 mg ml1], pep-
statin [0.7 mg ml1], aprotinin [1 mg ml1], and leupeptin [0.5 mg ml1]). Virus
particle suspensions were incubated overnight at 4°C in the presence of the
appropriate antibody. The next day, 3 mg protein A Sepharose was added to each
sample, and the suspensions were incubated at 4°C for another 2 h. The immune
complexes formed were washed three times with PBS, resuspended in 30 ml of
2 NuPAGE LDS sample buffer supplemented with 50 mM dithiothreitol, and
heated for 5 min at 100°C. To confirm the specificity of the affinity purification,
control experiments were performed without antibodies and with MAb1, which
is directed against the bovine herpesvirus type 1 gE/gI complex (36).
Radioimmunoprecipitations. To isolate radiolabeled viral proteins, lysates of
cells or of virus pellets were prepared in PBS-TDS (PBS containing 1 g sodium
dodecyl sulfate [SDS], 10 ml Triton X-100, and 5 g sodium desoxycholate per
liter) supplemented with protease inhibitors. The lysates were incubated over-
night at 4°C in the presence of the appropriate antibody. The next day, 3 mg
protein A Sepharose was added to each sample, and the samples were incubated
at 4°C for another 2 h. The immune complexes were washed three times with
PBS-TDS, resuspended in 30 ml of 2 NuPAGE LDS sample buffer supple-
mented with 50 mM dithiothreitol, and heated for 5 min at 100°C.
Endoglycosidase treatment. Endoglycosidase treatments were performed with
Endo--N-acetyl-D-glycosaminidase H (EndoH; New England Biolabs) and with
peptide N-glycosidase F (PNGaseF; New England Biolabs) according to the
manufacturer’s instructions.
Gel electrophoresis. Samples were analyzed by SDS-polyacrylamide gel elec-
trophoresis (PAGE) using a 12% polyacrylamide gel (NuPAGE). Gels were
fixed for at least 1 h in 40% (vol/vol) methanol and 10% (vol/vol) acetic acid and
dried on Whatman 3MM paper, and radioactivity was visualized by phosphorim-
aging (STORM-840). Intensities of the protein bands were quantified using
ImageQuant 5.1 image analysis software.
RNA isolation and RNA quantification. To investigate the relative amounts of
viral genomic RNA (as a measure of total viral particles), a real-time reverse
transcription (RT)-PCR was performed using the Light Cycler (Roche) as pre-
viously described (37).
Statistical analysis. Overall equality of the amounts of viral particles produced
by wild-type and mutant viruses, each expressed as relative amounts of RNA as
determined by RT-PCR, was tested using the Kruskal-Wallis test. Interesting
contrasts between groups of viruses or between different viruses were tested
using the permutation test. Significance levels were set at 5%. Statistical analyses
were performed with StatXact-5 for Windows (Cytel Software Corporation,
2001).
RESULTS
Requirement of the PRRSV envelope protein genes for in-
fectious virus production. To determine the requirement of
each of the PRRSV envelope proteins for the production of
infectious progeny, we generated full-length cDNA clones in
which the genes encoding the envelope proteins were disabled,
one at a time, either by mutation of their translation initiation
codon or by deletion of a major part of the ORF (Fig. 1A)
(KO2a, -2b, -3, -4, -5, and -6). BHK-21 cells were transfected
with in vitro RNA transcripts of the gene knockout constructs
and immunostained 24 h later with an antibody to the N pro-
tein. As judged from the expression of the N protein, which for
each KO mutant was similar to that of the wild-type (wt)
control, neither genome replication nor mRNA transcription
appeared to be affected in the gene knockout constructs.
BHK-21 cells are nonpermissive to PRRSV; hence, production
of infectious virus cannot be determined by monitoring the
spread of the infection through the transfected culture. To
investigate the presence of infectious progeny virus released by
the BHK-21 cells, the supernatants of these cultures were
inoculated onto PAMs, the natural host cells of PRRSV. The
results of the immunoassays performed 24 h p.i. revealed that
no or only few cells had become infected with any of the
mutants. In a typical experiment, up to approximately 0.1% of
the cells stained positive compared to about 20% in the case of
the wt. When the culture supernatants of these PAMs (p1)
were passaged once more onto fresh cells (p2), none of the
cells stained positive except for the cells inoculated with the wt
control. These observations are similar to those described pre-
viously in comparable experiments with EAV gene knockout
viruses (26, 49). From our results, we conclude that each of the
PRRSV envelope proteins is essential for infectious virus pro-
duction.
Membrane protein requirements for viral particle forma-
tion. Knowing the importance of each of the envelope proteins
for the virus, we subsequently investigated whether any of
these mutations affected the formation of viral particles.
BHK-21 cells transfected with in vitro transcripts of the differ-
ent full-length constructs were labeled in parallel with
Tran[35S] label. Particles released into the culture supernatant
were concentrated by sedimentation through a sucrose cush-
ion. The pellets were dissolved in PBS-TDS and subjected to
immunoprecipitation with an antibody to the N protein. SDS-
PAGE of the immunoprecipitates showed that the gene knock-
out constructs not expressing (functional forms of) the GP2a,
E, GP3, or GP4 protein were still capable of producing nonin-
fectious viral particles as judged by the appearance of the N
protein (Fig. 2A). However, in the absence of the GP5 or the
M protein, only traces of the nucleocapsid protein were ob-
served (approximately 6% of the wt), implying that GP5 and M
are both required for virion formation. The low amounts of N
protein detected in the culture medium most likely represent
intracellular N protein (nucleocapsids) released due to cell
lysis.
Rescue of PRRSV gene knockout mutants with constructs
expressing the lacking protein. To verify whether the inability
of our gene knockout constructs to produce infectious progeny
was indeed due to our intended mutations rather than to
changes unintentionally introduced in the full-length cDNAs,
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we performed complementation experiments using plasmids
expressing the missing proteins. For this purpose, we trans-
fected BHK-21 cells either with in vitro transcripts of full-
length construct KO2a or KO2b alone or together with pCIneo
constructs expressing the GP2a or the E protein, respectively.
An immunostaining experiment performed 24 h posttransfec-
tion with MAb 122.17 showed that N protein expression in-
duced by the gene knockout constructs was comparable to that
by the wt transcript (Table 2, passage p0 BHK-21). As ex-
pected, no virus replication was observed after inoculation of
PAMs with the supernatants of single-transfected BHK-21
cells (Table 2, p1 PAMs). On the other hand, inoculation of
PAMs with the culture supernatants of the double-transfected
BHK-21 cells resulted in infection as judged from the immu-
nopositive cells (Table 2, p1), indicating that the failure of our
knockout mutants to produce infectious progeny virus was
solely caused by the gene disruptions. When a second passage
(Table 2, p2) was performed, no virus replication was observed
except for the wt control, confirming that the infectious prog-
eny consisted of complemented virus particles only capable of
a single round of replication. Our observations are in agree-
ment with data published very recently by Welch et al. (40)
FIG. 2. Presence of virus-like particles in transfection supernatants. (A) Immunoprecipitation analysis of recombinant viruses. BHK-21 cells
were transfected with in vitro transcripts of the full-length constructs and labeled with Tran[35S] label. Virus-like particles in the culture
supernatants of the transfected cells were concentrated by sedimentation through a sucrose cushion. Pellets were dissolved in PBS-TDS and
subjected to immunoprecipitation with a MAb directed against the N protein. The immunoprecipitated proteins were analyzed in an SDS–12%
polyacrylamide gel. “N” indicates the position of the nucleocapsid protein. At the left, the positions and sizes (kilodaltons) of the molecular mass
marker proteins run in parallel (lane M) are shown. BHK-21 cells transfected with replication-negative mutant R were used as a negative control.
The intensities of the N-protein bands were quantified using ImageQuant5.1 image analysis software. The values (in percentages of wt) are shown
below the respective N-protein bands. (B) Quantification of relative amounts of viral RNA. BHK-21 cells were transfected with full-length RNA
transcripts. At 24 h posttransfection, culture supernatants were harvested, viral RNA was isolated, and a real-time RT-PCR was performed. Shown
are the mean values of two (KO3 and KO4) or four (wt, KO2a, KO2b, KO5, KO6, and R) experiments. A statistically significant difference
(P  0.05) was observed between wt/KO2a/KO2b/KO3/KO4 jointly on the one hand and KO5/KO6/R jointly on the other hand (“a” versus “b”).
In addition, a statistically significant difference (P  0.05) was observed between viral RNA levels obtained for wt and KO2a compared to KO2b
(“c” versus “d”).
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showing that infectious PRRSV lacking ORF2 or ORF4 can be
rescued by growth in complementing cell lines providing the
missing protein in trans. Similar complementation was re-
ported for EAV using cell lines expressing the minor envelope
proteins (49).
Release of viral RNA from cells transfected with mutant
viral RNA transcripts. To characterize the virus-like particles
produced in the absence of the GP2a, E, GP3, or GP4 protein,
we analyzed whether the particles present in the culture su-
pernatants of transfected cells contained viral RNA by using
real-time RT-PCR. A clear distinction was observed between
viral RNA levels obtained for mutants KO2a, KO2b, KO3, and
KO4 compared to those for KO5 and KO6 (Fig. 2B). Whereas
the amounts of RNA detected in the culture supernatants of
mutant viruses KO2a, KO2b, KO3, and KO4 were in the same
order of magnitude as that of the wt, the viral RNA levels of
KO5 and KO6 were dramatically reduced (1% of the wt) (Fig.
2B), consistent with the immunoprecipitation results. Closer
inspection of the relative amounts of viral RNA produced by
the KO2a, KO2b, KO3, and KO4 mutants revealed that while
the amount of viral RNA obtained for the KO2a mutant was
similar to that of wt virus, it was significantly reduced by about
two-thirds in the case of mutant KO2b. Viruses KO3 and KO4
also produced lower levels of viral RNA (50% of the wt), but
these amounts were statistically not significantly different from
those of the wt. The results are consistent with the interpreta-
tion that no viral particles are produced if either the GP5 or the
M protein is absent but that particle formation is only margin-
ally affected by the lack of any of the other envelope proteins.
Virion envelope composition in the absence of GP2a, E, GP3,
or GP4. Next, we analyzed the composition of the noninfec-
tious viral particles produced in the absence of one of the
minor envelope proteins. As these proteins are extremely dif-
ficult to detect in PRRSV preparations due to their low abun-
dance, we used an affinity purification assay to indirectly detect
their incorporation into virions using the presence of the N
protein as a readout parameter. Intact virus particles released
into transfected cell culture supernatants were affinity purified
by incubation with MAbs directed against epitopes in the
ectodomains of the proteins followed by collection of the par-
ticles using protein A-Sepharose. Purification of wild-type par-
ticles with either the anti-GP3 or the anti-GP4 antibody re-
vealed an intense N-protein band on SDS-PAGE (Fig. 3A and
B). In contrast, application of the procedure to KO2a, KO2b,
KO3, and KO4 using the same antibodies did not reveal any
detectable N protein (Fig. 3A and B). Note that the faint band
at the level of the N protein in the experiment depicted in Fig.
3A (panel 1) was not seen in other experiments (Fig. 3A, panel
2). In parallel, a control experiment was performed with an
anti-M antibody to ascertain the production of enveloped viral
particles (Fig. 3C). N-protein bands were seen for all con-
structs, confirming that such particles had indeed been pro-
duced. These results indicated that the incorporation of GP3
and GP4 into virus particles requires simultaneous expression
of all four minor envelope proteins, suggesting that these pro-
teins are assembled as a multimeric complex. Unfortunately,
FIG. 3. Composition of virus-like particles in the absence of minor envelope proteins. Radiolabeled virus-like particles were generated and
processed as described in the legend to Fig. 2. After sedimentation, virus-like particles were resuspended in PBS and subjected to affinity
purification. (A) Purification of particles with MAb anti-GP3 (-GP3). Panels 1 and 2 show the results of two representative experiments. (B)
Purification of particles with MAb anti-GP4 (-GP4). (C) Purification of particles with MAb anti-M (-M).
TABLE 2. Rescue of PRRSV gene knockout mutants with
constructs expressing the lacking protein
Mutant Complementa p0 BHK-21b p1 PAMsb p2 PAMsb
Wild type —   
KO2A —   
KO2A pCIneo-ORF2a   
KO2A SFV-ORF2   
KO2B —   
KO2B pCIneo-ORF2b   
KO2B SFV-ORF2   
a Expression constructs and recombinant SFV used for in trans complemen-
tation of the full-length gene knockout constructs. —, no complement added.
b Virus replication was analyzed by IPMA at 24 h posttransfection (BHK-21)
or postinfection (PAMs) using MAb 122.17 directed against the N protein. The
degree of positive staining is indicated by the number of plusses ( to ); no
staining is indicated by a minus ().
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no reactive antibodies were available for GP2a and E. Thus,
given the undetectable low amounts of radioactivity of the
different minor proteins in the viral particles, an analysis of the
effects of the different gene knockouts on the incorporation of
the other minor glycoproteins was not feasible.
Analysis of putative interactions between the minor enve-
lope proteins. The results obtained so far point to interactions
between the minor proteins as an essential requirement for
their particle assembly. To allow an alternative study of these
interactions, we completed a set of SFV recombinants by gen-
erating SFV-ORF3 (Fig. 1B). The constructs SFV-ORF2 (25)
and SFV-ORF4 (23, 25) have already been described. SFV-
ORF2 contains the coding sequences for the GP2a protein as
well as those for the small E protein. To establish whether the
E protein is indeed expressed from this vector, we included it
in our complementation experiments. As shown in Table 2,
cotransfection of BHK-21 cells with in vitro RNA transcripts of
SFV-ORF2 and of full-length construct KO2a or KO2b re-
sulted in successful complementation. These observations in-
dicated that both the GP2a protein and the E protein are
correctly expressed from the alphavirus vector, rendering our
collection of SFV vectors suitable for studying interactions
between the minor proteins.
When the SFV-ORF2 and SFV-ORF4 vectors were sepa-
rately expressed in BHK-21 cells, the GP2a and GP4 glycopro-
teins were apparently retained in the ER as their N-glycans
remained endoglycosidase H (EndoH) sensitive (25; J. J. M.
Meulenberg, unpublished results). Led by this observation, we
hypothesized that the minor glycoproteins might acquire trans-
port competence only when assembled into a multimeric com-
plex. We therefore studied their interaction by assessing their
ability to be transported through the Golgi complex when
coexpressed in different combinations in BHK-21 cells. Trans-
port competence was assessed by analyzing their sensitivity to
EndoH and peptide N-glycosidase F (PNGaseF). We started
by checking our newly obtained SFV-ORF3 vector and ana-
lyzed the independent expression and transport of the GP3
protein in BHK-21 cells. The protein immunoprecipitated
from radiolabeled cell lysates migrated in gel at approximately
45 kDa. EndoH treatment reduced the apparent molecular
mass to about 29 kDa, consistent with the removal of possibly
seven N-linked glycans (Fig. 4A). The GP2a and GP4 proteins
have previously been shown to become EndoH resistant over
time when expressed in cells infected with LV, being fully
EndoH resistant in the extracellular virus particles (23, 25).
Analysis of the GP3 protein in LV-infected MARC-145 cells
indicated that the GP3 protein behaved slightly different (Fig.
4B and C). Even after a chase time of 300 min, the glycoprotein
immunoprecipitated from the infected cell lysate was still
largely immature in its oligosaccharides. The GP3 protein ap-
peared as a discrete band of approximately 45 kDa that was
reduced to about 29 kDa after treatment with EndoH and
PNGaseF (Fig. 4B), similar to the independently expressed
protein (Fig. 4A). However, as for GP2d and GP4, in extracel-
lular virions, only the mature, EndoH-resistant form of the
GP3 protein was detected (Fig. 4C). Here, the glycoprotein
appeared as a fuzzy band of approximately 50 to 60 kDa,
presumably due to the extensive and heterogeneous matura-
tion of its N-linked glycans. The apparent size of the virion-
derived GP3 was reduced to 29 kDa by removal of the oligo-
saccharides with PNGaseF, confirming the identity of the GP3
protein (Fig. 4C).
Interactions between GP2a, GP3, and GP4 are required for
transport to the Golgi. Next, we studied the transport behavior
of the minor structural proteins when coexpressed. BHK-21
cells were coinfected with different combinations of the recom-
binant SFV viruses at an MOI of approximately 5 each to
ensure that most cells were infected by two or three different
viruses. The degree of infection (90 to 100%) was confirmed in
an immunostaining assay (data not shown). Cells were pulse-
labeled for 30 min, chased for up to 300 min, and lysed, after
which the glycoproteins were immunoprecipitated, and the
FIG. 4. Immunoprecipitation analysis of GP3 expressed by SFV-ORF3 or by LV. (A) GP3 was immunoprecipitated with anti-GP3 (-GP3) from
lysates of BHK-21 cells infected with SFV-ORF3 at an MOI of 5. At 18 h p.i., the cells were starved for methionine for 30 min and subsequently
labeled with L-[35S]methionine for 30 min. The cells were then chased with 5 mM nonradioactive L-methionine for 0, 150, and 300 min. (B) GP3
was immunoprecipitated with -GP3 from lysates of MARC-145 cells infected with LV4.2.1. Cells were infected with LV4.2.1 at an MOI of 2, and
at 18 h p.i., they were labeled with L-[35S]methionine for 30 min and chased for 300 min. (C) GP3 was immunoprecipitated with -GP3 from
extracellular LV4.2.1 virions labeled and purified by sedimentation through a sucrose cushion as described previously (25). Immunoprecipitates
were treated with EndoH (H) or PNGaseF (F) or were left untreated (U).
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maturation state of their glycans was analyzed using EndoH. It
appeared that in the three possible combinations where two
glycoproteins (and the E protein) were coexpressed none of
the proteins became EndoH resistant (Fig. 5). Also, when
we replaced one of the three recombinant SFV viruses by
SFV-ORF5, no maturation was observed for any of the
glycoproteins involved (data not shown). Only when GP2a
plus E, GP3, and GP4 were expressed together did the ma-
jority of the proteins become EndoH resistant after a chase
period of 300 min (Fig. 5), indicating that simultaneous
expression of all minor glycoproteins (and presumably of the
E protein) is essential for their transport. The size of the
EndoH-sensitive form of the GP4 protein seemed to de-
crease slightly during the chase period, irrespective of the
FIG. 5. EndoH sensitivities of coexpressed GP2a, GP3, and GP4 proteins. BHK-21 cells were coinfected with different combinations of
SFV-ORF2a, SFV-ORF3, and SFV-ORF4 as indicated above the lanes. The cells were pulse-chase labeled as described in the legend to Fig. 4A.
The cells were lysed, and the GP2a, GP3, and GP4 proteins were subjected to immunoprecipitation with anti-GP2a (-GP2a), anti-GP3 (-GP3),
or anti-GP4 (-GP4) antibodies. Precipitates were either left untreated (EndoH; left-hand panels) or treated with EndoH (EndoH; right-hand
panels).
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presence of other glycoproteins. As the size of the deglyco-
sylated backbone of GP4 did not change, the observed de-
crease in size might be due to some intermediate changes
(trimming) of the N-glycan moieties.
Interaction of GP2a, GP3, and GP4 leads to secretion of
proteins into the medium. To investigate whether the interac-
tions between the GP2a, GP3, and GP4 proteins resulted in
release of the proteins into the extracellular medium, we ana-
lyzed the culture supernatants of BHK-21 cells infected with
the individual SFV recombinants or coinfected with all three
SFV recombinant viruses. Individual expression of the minor
glycoproteins did not lead to any detectable GP2a or GP4 in the
medium of SFV-ORF2- or SFV-ORF4-infected BHK-21
cells after a 300-min chase (data not shown). In contrast, a
small amount of GP3 was precipitated from the medium of
BHK-21 cells infected with SFV-ORF3 only (Fig. 6A).
Treatment of the immunoprecipitated GP3 protein with
EndoH showed that this secreted product was EndoH resis-
tant (Fig. 6A). After treatment with PNGaseF, the size of
GP3 was similar to that of the fully deglycosylated form
obtained from the cell lysate (Fig. 6B). Analysis of the
culture supernatant of BHK-21 cells coinfected with SFV-
ORFs 2, 3, and 4 showed that, besides GP3, GP2a and GP4
were also now detected in the culture medium after a chase
period of 300 min (Fig. 6C). The GP2a and GP4 proteins
were both resistant to EndoH (data not shown) and sensitive
to PNGaseF (Fig. 6C). To check whether the appearance of
GP2a, GP3, and GP4 in the extracellular medium was not
due to lysis of the cells, we performed a control experiment
in which we subjected the medium of BHK-21 cells infected
with SFV-ORF4 to immunoprecipitation with anti-GP4. No
GP4 was detected (data not shown). Hence, we conclude
that coexpression of GP2a/E, GP3, and GP4 resulted in
transport of these proteins from the ER through the Golgi
complex followed by their release into the culture medium.
DISCUSSION
In the present study, we investigated the structural require-
ments for PRRSV virion formation and infectivity using full-
length cDNA clones in which the genes encoding the mem-
brane proteins were disrupted by site-directed mutagenesis.
From our results, we draw three main conclusions. First of all,
each of the membrane proteins is essential for the production
of infectious virus. Second, the GP5 and M protein are both
crucial for particle formation, consistent with a role as the
fundamental building blocks of the viral envelope. Third, while
not required for particle assembly, the minor glycoproteins
GP2a, GP3, and GP4, and probably also the minor envelope
protein E, interact with each other. This interaction is likely to
be of critical importance for their incorporation as heteromul-
timeric complexes into PRRSV particles and essential for ren-
dering these particles infectious.
Until recently, the GP5 protein and, to a lesser extent, the M
protein were considered to have their main function in the
targeting of arteriviruses to and their entry into cells. This view
changed drastically after Dobbe et al. (5) demonstrated that
replacing the ectodomain of the EAV GP5 by that of the
homologous proteins of PRRSV and LDV in the context of a
full-length cDNA clone did not alter the tropism of the result-
ing chimeric viruses. Similarly, replacement of the ectodomain
of the M protein of PRRSV by that of other arteriviruses also
did not change viral tropism (39). While a role of these pro-
teins in cell entry can still not be ruled out (in fact, data by
Delputte et al. [4] demonstrate a contribution to PRRSV host
cell attachment through their interaction with a heparin-like
receptor), the great abundance of GP5-M heterodimers in the
viral envelope argues for a primary function of these proteins
in viral structure and assembly. The dramatic effect on particle
production that we observed here when the synthesis of either
of the proteins was disabled strongly supports this view. The
FIG. 6. Analysis of GP2a, GP3, and GP4 released into the medium of BHK-21 cells. (A) Immunoprecipitation of the GP3 protein from the
medium of BHK-21 cells infected with SFV-ORF3. Cells were pulse-chase labeled as described in the legend to Fig. 4A. Immunoprecipitates were
treated with EndoH (H) or left untreated (U). (B) Immunoprecipitation of the GP3 protein from the cell lysate (Lys) and medium of BHK-21 cells
infected with SFV-ORF3. The cells were pulse-labeled, followed by a chase of 300 min. Immunoprecipitates were treated with PNGase F (F) or
left untreated (U). (C) Immunoprecipitation of GP2a, GP3, and GP4 proteins from the medium of BHK-21 cells coinfected with SFV-ORF2a,
SFV-ORF3, and SFV-ORF4. At 4 h p.i., the cells were pulse-labeled, followed by a chase of 300 min. The medium was harvested, and the GP2a,
GP3, and GP4 proteins were subjected to immunoprecipitation with anti-GP2a (-GP2a), anti-GP3 (-GP3), or anti-GP4 (-GP4) antibodies.
Precipitates were either treated with PNGaseF (F) or left untreated (U). The arrows indicate the respective proteins.
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disulfide bond between GP5 and M presumably occurs between
cysteine residues at positions 50 and 8, respectively (38). Mu-
tating either one of these residues resulted in a complete block
of particle production (38), indicating that the covalent asso-
ciation of GP5 and M is crucial for assembly. The same holds
true for EAV where the homologous GP5 and M proteins were
also found to be required for particle formation (43) and where
the essential requirement for heterodimerization between GP5
and M proteins was also shown by mutagenesis of the cysteine
residues involved (31).
PRRSV particle assembly is not dependent on the minor
proteins. Analysis of viral protein and RNA in the culture
media of cells transfected with single gene knockout constructs
revealed that in all four cases, RNA-containing particles were
released. Except when the E protein was lacking, which led to
a significant decrease, the amounts of particles produced were
not much lower than the amount of virus obtained with the
wild-type construct. Interestingly, the absence of any of the
four proteins appeared to affect the incorporation of all three
others. Thus, no GP3 was detected in particles when the ex-
pression of either GP2a, or E, or GP4 was prevented, and no
detectable GP4 was incorporated in the absence of GP2a, E,
and GP3. Similar observations were made with EAV. However,
though strongly reduced, some E protein continued to be in-
corporated into EAV particles in the absence of each of the
minor glycoproteins (43), a feature we could not establish for
PRRSV due to the lack of an E-specific antibody.
The interdependence of the minor PRRSV envelope pro-
teins for their incorporation into virions strongly indicated that
these proteins have to associate in infected cells to form het-
eromultimeric complexes prior to or during their assembly into
virions. The low abundance of these proteins in viral particles
prevented the direct demonstration of such complexes. Indi-
rect evidence was, however, obtained by using a biological
feature, i.e., intracellular transport, as an indicator for their
interaction. By analyzing the maturation state of the N-linked
oligosaccharides, we observed that the minor glycoproteins
were each retained in the ER region of the cell when expressed
individually or together with one of the others. They acquired
transport competence, however, when they were all coex-
pressed together, in which case they were collectively carried
through the Golgi complex to the plasma membrane and even
detected in the extracellular medium. Since GP2a, GP3, and
GP4 are envelope proteins, it is most likely that they associated
in membranous structures, presumably in the form of particles.
Although the identification of these structures was beyond the
scope of this study, we performed an electron microscopic
analysis of BHK-21 cells in which GP2a, GP3, and GP4 had
been coexpressed and of the medium of these cells, but this did
not reveal any virus-like particles.
As the ORF encoding the E protein is fully contained within
the sequence encoding GP2a, our experiments do not allow
conclusions about the specific contribution of the E protein to
the interaction process. Our results are consistent with those
reported recently for EAV. Here, the occurrence of a co-
valently linked GP2b/GP3/GP4 complex in virions could be di-
rectly demonstrated. Interestingly, while the disulfide linkage
between the EAV GP2b and GP4 proteins appeared to be
formed intracellularly, the covalent association of GP3, pre-
sumably by linking to GP4 (46), occurs after the assembled
virus has been released from the infected cell (45). Whether or
not the proteins in the PRRSV complex are also covalently
linked is presently unclear. In this respect, it is of note that the
cysteine residue (Cys102), which in GP2b of EAV is supposedly
responsible for the formation of the cystine bridge with GP4
(46), is not conserved in the GP2a protein of PRRSV (10).
As argued above, the GP5-M heterodimers are unlikely to
play a predominant role in arterivirus targeting and/or entry.
Hence, this function should be attributed to the minor pro-
teins. As these proteins occur in particles as heteromultimeric
complexes, they probably constitute the virion-exposed struc-
ture that mediates binding of the virion to the primary recep-
tor, which has not yet been identified for any arterivirus except
for PRRSV, where a macrophage-restricted sialoadhesin was
found to be involved (34). PRRSV binding to sialoadhesin
leads to clathrin-mediated internalization of the virion into an
endosome. A subsequent drop in pH in the endosome is re-
quired for PRRSV replication (17, 28). For other viruses such
as orthomyxo- and alphaviruses (14, 29), it has been observed
that an acidic pH triggers a conformational change in the
fusion protein(s) that ultimately leads to the fusion of the viral
and endosomal membranes and the delivery of the nucleocap-
sid into the cell’s cytoplasm. If the arterivirus minor protein
complex would indeed be involved in this fusion process, its
unique nature and composition would point to a fusion mech-
anism that is significantly different from the recently described
class I and class II mechanisms that drive the fusion of, for
instance, influenza viruses (7, 33) and flaviviruses (13), respec-
tively.
The GP3 protein seems to take a special position among the
arterivirus glycoproteins. While its membrane topology has not
been resolved and remains speculative (12, 44), its virion struc-
tural nature is also still controversial. For LDV, the GP3 pro-
tein was reported to be a nonstructural, soluble glycoprotein
that is secreted from infected cells (9). In contrast, the GP3
protein of EAV was clearly demonstrated to be incorporated
into virions (44). For PRRSV, both situations have been de-
scribed. Thus, the GP3 protein of the prototype European
strain LV was found to be incorporated into virions (35),
whereas that of North American strains was observed to occur
as a secreted protein (sGP3) (11, 19). In the present study, we
provided new evidence for the incorporation of the GP3 pro-
tein into LV particles, but additionally, we demonstrated the
independent secretion of a substantial amount of GP3 by cells
expressing the protein from an alphavirus vector. This dual
nature of GP3 is reminiscent of glycoproteins of several other
viruses such as the glycoproteins G (gG) of alphaherpesviruses
(1, 27) and the Erns glycoprotein of BVDV (15). The gG
protein of alphaherpesviruses is found in the virus envelope
and, in some alphaherpesviruses, is also secreted after proteo-
lytic processing. Recently, these secreted forms of gG were
reported to have chemokine binding activity, thereby inhibiting
the biological activity of these chemokines in vitro (1). The
BVDV Erns protein, in addition to being a virion protein, is
also secreted from infected cells into the extracellular environ-
ment. This secreted form was recently shown to block the
double-stranded RNA interferon-inducing signal (15).
Whether the secreted PRRSV GP3 protein is also of physio-
logical relevance remains to be established.
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